Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin
Zeevi, A.; Woan, M.; Yao, G.Z.; Venkataramanan, R.; Todo, S.; Starzl, T.E.; Duquesnoy, R.J.
Transplantation Proceedings 23(6): 2928-2930
1991
ISSN/ISBN: 0041-1345 PMID: 1721315 Document Number: 378373
Document emailed within 1 workday
Related Documents
Ohsugi, Y.; Suzuki, S.; Takagaki, Y. 1976: Antitumor and immunosuppressive effects of mycophenolic acid derivatives Cancer Research 36(8): 2923-2927Christians, U.; Sattler, M.; Schiebel, H.M.; Kruse, C.; Radeke, H.H.; Linck, A.; Sewing, K.F. 1992: Isolation of two immunosuppressive metabolites after in vitro metabolism of rapamycin Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(2): 186-191
Wu, J.; Palladino, M.A.; Figari, I.S.; Morris, R.E. 1991: Comparative immunoregulatory effects of rapamycin, FK 506 and cyclosporine on mitogen-induced cytokine production and lymphoproliferation Transplantation Proceedings 23(1 Part 1): 238-240
Aso, K.; Uchida, H.; Sato, K.; Yokota, K.; Osakabe, T.; Nakayama, Y.; Ohkubo, M.; Kumano, K.; Endo, T.; Koshiba, K. 1987: Immunosuppression with low-dose cyclosporine combined with bredinin and prednisolone Transplantation Proceedings 19(1 Pt 3): 1955-1958
Griffin, K.E.; Slocombe, B. 1989: Comparative activities in vitro of timentin (ticarcillin/clavulanic acid) and ureidopenicillins against ampicillin-resistant clinical isolates Journal of ChemoTherapy 1(4 Suppl): 267-269
Durette, P.L.; Boger, J.; Dumont, F.; Firestone, R.; Frankshun, R.A.; Koprak, S.L.; Lin, C.S.; Melino, M.R.; Pessolano, A.A.; Pisano, J. 1988: A study of the correlation between cyclophilin binding and in vitro immunosuppressive activity of cyclosporine a and analogues Transplantation Proceedings 20(2 Suppl 2: 51-57
van der Nat, J.M.; Beijnen, J.H.; Driebergen, R.J.; Thart, L.A.; van Dijk, H.; Underberg, W.J.; Labadie, R.P. 1988: In vitro immunosuppressive activities of recently developed anthracycline cytostatics Anticancer Research 8(3): 489-493
Jastalska, D.; Dzierzyńska, I.; Buśko-Oszczapowicz, I.; Cieślak, J. 1974: Semisynthetic penicillins. 13. Comparative studies of antibacterial action in vitro of 6-(N,N-1',6'-hexylenformamidino)-penicillanic acid and(D- (D-(minus) alpha-aminobenzyl)-penicillanic acid against clinical pathogenic gram negative strains Acta Poloniae Pharmaceutica 31(3): 393-400
Chen, H.F.; Wu, J.P.; Luo, H.Y.; Daloze, P.M. 1991: The immunosuppressive effect of rapamycin on pancreaticoduodenal transplants in the rat Transplantation Proceedings 23(4): 2239-2240
Neyts, J.; Andrei, G.; De Clercq, E. 1998: The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo Antimicrobial Agents and ChemoTherapy 42(2): 216-222
Hewitt, C.W.; Black, K.S. 1988: Comparative studies of FK506 with cyclosporine Transplantation 46(3): 482-483
Nickmilder, M.J.; Latinne, D.; De Houx, J.P.; Verbeeck, R.K.; Lhoëst, G.J. 1998: Isolation and identification of a C39 demethylated metabolite of rapamycin from pig liver microsomes and evaluation of its immunosuppressive activity Clinical Chemistry 44(3): 532-538
Baumann, G.; Andersen, E.; Quesniaux, V.; Eberle, M.K. 1992: Cyclosporine and its analogue SDZ IMM 125 mediate very similar effects on T-cell activation--a comparative analysis in vitro Transplantation Proceedings 24(4 Suppl 2: 43-48
Stepkowski, S.M.; Tu, Y.; Chou, T.C.; Kahan, B.D. 1994: Synergistic interactions of cyclosporine, rapamycin, and brequinar on heart allograft survival in mice Transplantation Proceedings 26(5): 3025-3027
Ferraresso, M.; Knight, R.; Tu, Y.; Stepkowski, S.M.; Kahan, B.D. 1994: Triple combination of cyclosporine, brequinar, and rapamycin prolongs kidney allograft survival in the mongrel dog Transplantation Proceedings 26(5): 3028
Takeshita, K.; Fukazawa, I.; Nakaike, S.; Kameo, K.; Tomisawa, K.; Otomo, S.; Aihara, H. 1988: Immunopharmacological studies of new 3-benzoyl-4-mercaptobutyric acid derivatives. II. Immunosuppressive effects Drugs under Experimental and Clinical Research 14(5): 311-318
Nakagawa, Y.; Ikeda, M.; Tasaki, M.; Saito, K.; Takahashi, K. 2013: The new immunosuppressive drugs for renal transplantation: inhibitors of the mammalian target of rapamycin (mTOR) and anti-thymocyte globulin (Thymoglobulin) Nihon Jinzo Gakkai Shi 55(2): 112-118
Hermann, G.; Littmann, E.; Sesterhenn, K.; Dostal, G. 1972: Comparative kinetic studies on the suppression of primary cellular immune response by various immunosuppressive agents Verhandlungen der Deutschen Gesellschaft für Innere Medizin 78: 853-857
Balogh, F.; Köves, S.; Kocsis, B. 1977: Examinations with oxolinic acid and nalidixic acid: (comparative study on the in vitro and therapeutic action) Therapia Hungarica 25(3): 111-114
Monaco, A.P.; Gozzo, J.J.; Wood, M.L.; Pompei, R. 1973: Further studies on the in vitro assay of immunosuppressive potency of antilymphocyte serum by the mixed agglutination technique Transplantation Proceedings 5(1): 527-531